| 2010 |
Peter Cullis, Ph.D., Professor, Biochemistry & Molecular Biology, University of British Columbia/ CDRD, Vancouver, BC;
Anne Tomalin, President, i3 CanReg Inc., Dundas, Ontario
|
| |
| 2009 |
Helen Burt, Ph.D., Angiotech Professor of Drug Delivery and Associate Dean, Research and Graduate Studies, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC |
| |
| 2008 |
Robert Young, Ph.D., Professor of Chemistry and Merck Frosst-BC Leadership Chair in Pharmaceutical Genomics, Bioinformatics and Drug Discovery at Simon Fraser University; Co-Director of the Division of Drug Design and Synthesis at UBC and Simon Fraser University; and the President of Promorpheus Consultants Inc., Burnaby, BC
|
| |
| 2007 |
Lorne A. Babiuk, OC, SOM, Ph.D., D.Sc., FRSC, Director of the Vaccine and Infectious Disease Organization (VIDO) and Canada Research Chair in Vaccinology and Biotechnology in Saskatoon, Saskatchewan. |
| |
| 2005 |
John L. Wallace, Ph.D., Professor, Department of Pharmacology & Therapeutics, University of Calgary, Calgary, Alberta |
| |
| 2004 |
Theresa M. Allen, Ph.D., Professor, Department of Pharmacology, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta |
| |
| 2003 |
Marc LeBel, Pharm.D., President and Chief Executive Officer, Anapharm Inc. |
| |
| 2002 |
Julia Levy, Ph.D., Executive Chairman, Scientific Advisory Board, QLT;
David H. Dolphin, Ph.D., Executive Chairman, Scientific Advisory Board, QLT, Vancouver |
| |
| 2001 |
Fakhreddin Jamali, Ph.D., Professor, Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta (CSPS/DuPont Pharma Award of Leadership in Pharmaceutical Research & Development), Edmonton, AB |
| |
| 2000 |
Elizabeth Vadas, Ph.D., Executive Director, Pharmaceutical R&D, Merck Frosst (CSPS/DuPont Pharma Award Of Leadership In Canadian Pharmaceutical Sciences) |